CSIMarket


Dexcom Inc   (DXCM)
Other Ticker:  
 

Dexcom Inc

DXCM's Fundamental analysis








Looking into Dexcom Inc growth rates, revenue grew by 26.94 % in IV. Quarter 2023 from the same quarter a year ago. Ranking at No. 195

Medical Equipment & Supplies industry recorded growth of revenues by 8.27 %

Dexcom Inc 's net income grew by 179.19 % in IV. Quarter 2023 year on year, above company average,

More on DXCM's Growth


Dexcom Inc
current PE on trailing twelve month basis is above Medical Equipment & Supplies industry average.

Dexcom Inc realized cash outflow of $ -0.18per share in trailing twelve-month period.
Company
89.96
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 13.36.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.42.


More on DXCM's Valuation
 
 Total Debt (Millions $) 2,434
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 574,905
 Net Income/Employee (TTM) $ 85,952
 Receivable Turnover (TTM) 4.6
 Tangible Book Value (Per Share $) 4.58

Dexcom Inc
current PE on trailing twelve month basis is above Medical Equipment & Supplies industry average.

Dexcom Inc realized cash outflow of $ -0.18per share in trailing twelve-month period.
Company
89.96
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 13.36.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.42.

Dexcom Inc Price to Book Ratio is at 23.39 higher than Indusry Avg. of -349.9, and higher than S&P 500 Avg. of -2103.47

More on DXCM's Valuation

  Market Capitalization (Millions $) 48,389
  Shares Outstanding (Millions) 417
  Employees 6,300
  Revenues (TTM) (Millions $) 3,622
  Net Income (TTM) (Millions $) 542
  Cash Flow (TTM) (Millions $) -76
  Capital Exp. (TTM) (Millions $) -237
  Total Debt (Millions $) 2,434
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 574,905
  Net Income/Employee(TTM) $ 85,952
  Receivable Turnover Ratio (TTM) 4.6
  Tangible Book Value (Per Share $) 4.58

  Market Capitalization (Millions $) 48,389
  Shares Outstanding (Millions) 417
  Employees 6,300
  Revenues (TTM) (Millions $) 3,622
  Net Income (TTM) (Millions $) 542
  Cash Flow (TTM) (Millions $) -76
  Capital Exp. (TTM) (Millions $) -237


    DXCM's Profitability Comparisons
Dexcom Inc faced margin deterioraten, primarily through cost control. Operating Margin fell in IV. Quarter 2023 to 20.96 % from 21.09 % in III. Quarter.

Dexcom Inc net profit margin of 24.77 % is currently ranking no. 3 in Medical Equipment & Supplies industry, ranking no. 19 in Healthcare sector and number 236 in S&P 500.





  Ratio
   Capital Ratio (MRQ) 2.92
  Total Debt to Equity (MRQ) 1.18
  Tangible Leverage Ratio (MRQ) 2.14
  Asset Turnover Ratio (TTM) 0.58
  Inventory Turnover Ratio (TTM) 2.89



Dexcom Inc faced margin deterioraten, primarily through cost control. Operating Margin fell in IV. Quarter 2023 to 20.96 % from 21.09 % in III. Quarter.

Dexcom Inc net profit margin of 24.77 % is currently ranking no. 3 in Medical Equipment & Supplies industry, ranking no. 19 in Healthcare sector and number 236 in S&P 500.

More on DXCM's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com